Jooyeon Jamie Im

Jooyeon Jamie Im

Auto-generated profile, based on publicly available information

Jooyeon Jamie Im

Department of Nuclear Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Ultrasonography
Verified
Journal Article
Open access
PDF file
HJHyeonseok Jeong
Hyeonseok Jeong
JIJooyeon Jamie Im
Jooyeon Jamie Im
JPJong-Sik Park
Jong-Sik Park
SNSeunghee Na
Seunghee Na
WLWonhye Lee
Wonhye Lee
Yong An ChungYong An Chung
Yong An Chung
Purpose: Increasing attention has been paid to low-intensity transcranial focused ultrasound (tFUS) for its potential therapeutic effects in Alzheimer's disease (AD). While preclinical studies have shown promising therapeutic effects of low-intensity tFUS in AD models, its efficacy and safety remain unclear in humans. In this pilot study, we investigated the effects of low-intensity tFUS on blood-brain barrier opening, the regional cerebral metabolic rate of glucose (rCMRglu), and cognition in patients with AD.Methods: After receiving institutional review board approval, four patients with AD received tFUS to the hippocampus immediately after an intravenous injection of a microbubble ultrasound contrast agent. Sonication was delivered at low-intensity, at a pressure level below the threshold for blood-brain barrier opening. Patients underwent brain magnetic resonance imaging, 18F-fluoro-2-deoxyglucose positron emission tomography, and neuropsychological assessments before and after the tFUS procedure. A whole-brain voxel-wise paired t test was conducted to compare rCMRglu before and after tFUS.Results: The sonication, as anticipated, did not show evidence of active blood-brain barrier opening on T1 dynamic contrast-enhanced magnetic resonance imaging. rCMRglu in the superior frontal gyrus (P<0.001), middle cingulate gyrus (P<0.001), and fusiform gyrus increased after tFUS (P=0.001). Patients demonstrated mild improvement in measures of memory, executive, and global cognitive function following tFUS. No adverse events were reported.Conclusion: These results suggest that hippocampal sonication with low-intensity tFUS may have beneficial effects on cerebral glucose metabolism and cognitive function in patients with AD. Further larger studies are needed to confirm the therapeutic efficacy of tFUS in AD.

24 November 2019 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
ISIn-Uk Song
In-Uk Song
SNSeunghee Na
Seunghee Na
JIJooyeon Jamie Im
Jooyeon Jamie Im
HJHyeonseok Jeong
Hyeonseok Jeong
SCSung‐Woo Chung
Sung‐Woo Chung
Yong An ChungYong An Chung
Yong An Chung

28 August 2019 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
JIJooyeon Jamie Im
Jooyeon Jamie Im
HJHyeonseok Jeong
Hyeonseok Jeong
YCYong‐An Chung
Yong‐An Chung
JPJong‐Sik Park
Jong‐Sik Park
YHYoungje Heo
Youngje Heo
ISIn-Uk Song
In-Uk Song

17 September 2025 in bioRxiv
Verified
Preprint
Open access
JIJooyeon Jamie Im
Jooyeon Jamie Im
HKHyeonjin Kim
Hyeonjin Kim
JLJeung-Hyun Lee
Jeung-Hyun Lee
HPHyung Jun Park
Hyung Jun Park
HJHee-Kyung Joh
Hee-Kyung Joh
WAWoo-Young Ahn
Woo-Young Ahn
Background: Tobacco smoking continues to be a leading cause of preventable morbidity and mortality globally, with the success rate of unaided cessation remaining consistently low. Understanding the neurobiological mechanisms of smoking cessation is crucial for improving quit rates. However, there has been a lack of studies examining brain network changes associated with smoking cessation over time. In this study, we aimed to investigate longitudinal changes in the functional connectivity (FC) of large-scale brain networks underlying smoking cessation outcomes using resting-state functional magnetic resonance imaging (fMRI). Methods: A total of 98 treatment-seeking smokers participated in a 6-week cessation program and underwent resting-state fMRI scans before and after the intervention. Independent component analysis identified the salience network (SN), executive control network (ECN), and default mode network (DMN) components, and region of interest (ROI)-to-ROI FC was compared between successful and unsuccessful quitters using a group × time mixed-effects model. Correlations with smoking-related measures were explored. Results: Significant group-by-time interaction effects were found in FC, particularly involving connections between SN and ECN, as well as between the SN and DMN. Specifically, successful quitters exhibited greater baseline FC in the SN-ECN and SN-DMN circuits, which tended to normalize during the cessation process. Exploratory correlational analyses revealed trends suggesting that stronger pre-quit connectivity between the SN and ECN was associated with greater withdrawal severity and longer smoking history in successful quitters. Conclusions: Taken together, the normalization of initially elevated pre-quit FC in SN-ECN and SN-DMN circuits may reflect an adaptive neural process that supports successful withdrawal management and attentional reallocation during cessation. The identification of these neural substrates not only enhances our mechanistic understanding of smoking cessation over time but also underscores the need for targeted interventions that focus on these neural circuits to enhance quit outcomes.

4 December 2025 in PsyArXiv
Verified
Preprint
Open access
JIJooyeon Jamie Im
Jooyeon Jamie Im
ESEunsol So
Eunsol So
KKKipyo Kim
Kipyo Kim
WAWoo-Young Ahn
Woo-Young Ahn
Purpose of Review Despite the growing number of studies on interoception in addiction research, a comprehensive review of these findings is still lacking. The goal of this paper was to conduct a systematic review of empirical studies to assess the evidence for interoceptive deficits in individuals with substance use disorders (SUDs), identify gaps in the existing literature, and propose directions for future research.Recent FindingsFrom 1,544 records identified in APA PsycINFO, PubMed, CINAHL, and Embase using predefined search terms, 39 studies met eligibility criteria. Of these, 14 examined alcohol use disorder, 12 heterogeneous substance use, 6 opioid use disorder, 4 smokers, 2 cocaine use disorder, and 1 cannabis use. With respect to interoceptive domains (accuracy, sensibility, awareness), 12 studies assessed accuracy only, 19 assessed sensibility only, and 8 measured both; only one study additionally evaluated interoceptive awareness. Behavioral tasks (e.g., heartbeat counting) and self-report questionnaires (e.g., Multidimensional Assessment of Interoceptive Awareness; MAIA) were the most common measures of interoceptive accuracy and sensibility, respectively. Neuroimaging work was scarce, with only four studies examining neural correlates.SummaryAcross studies of interoception in SUDs, the most consistent pattern is reduced interoceptive accuracy relative to healthy controls, particularly in alcohol use disorder where impairments were most robust, though findings for other substances showed greater variability. Evidence for interoceptive sensibility is mixed, and work on interoceptive awareness remains sparse. The literature is constrained by a narrow emphasis on two dimensions and by heavy reliance on the heartbeat counting task, which has been widely criticized for validity concerns. Future research should assess multiple interoceptive dimensions across modalities, develop and validate more robust measures, and address potential confounders such as smoking status.